The LUminate™ Support Program provides your patients with a variety of tools and resources to help them get through opioid withdrawal, including:

LUCEMYRA® Commercial Access Program

All commercially insured patients are eligible to receive LUCEMYRA for $25*


(Please note this form acts as a prescription)

Patients who prefer to give authorization to a family member or 3rd party to help with correspondence and decision-making through the Commercial Access Program should fill out a Patient Designee Form.

*Terms and Conditions
Eligibility for the Commercial Access Program is limited to patients who are residents of the United States. Not valid for patients who are covered by any state or federally funded healthcare program, including but not limited to Medicare (Part D or otherwise), Medicaid, Medigap, CHAMPUS, TRICARE, and any state pharmaceutical assistance program; for patients who are Medicare eligible and enrolled in an employer-sponsored health plan or prescription benefit program for retirees; or patients whose insurance plan is paying the entire cost of this prescription.

Eligible patients may pay as little as $25 on their LUCEMYRA prescription.

LUCEMYRA Prescription Savings Co-Pay Assistance Program

The LUCEMYRA Prescription Savings Co-Pay Assistance Program helps provide cost savings to eligible patients so that these patients can get the prescription they need as prescribed by their healthcare provider.

Patients will be able to print out their program savings card or bookmark it on their smartphone. When they provide their pharmacy with the ID number on the card, they will get their LUCEMYRA prescription discount.

Depending upon the participating pharmacy, the LUCEMYRA discount may be provided by McKesson, Relay Health eVoucherRx Program, or eRx Network. Relay Health eVoucherRx Program and eRx Network are both paperless, and the discount is automatically applied at the pharmacy counter. McKesson is the only program that requires patients to provide the pharmacy with the ID number from their savings card to obtain the discount.

Patients whose prescriptions are paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program, are not eligible for savings or rebates according to federal and state law. Patients must visit a participating pharmacy for savings or rebates on their LUCEMYRA prescriptions. Maximum benefits may apply.

The actual savings and out-of-pocket costs for LUCEMYRA will vary according to refill quantity, personal healthcare insurance coverage, and adherence to FDA dosing guidelines. Please review Terms and Conditions to learn more.

To answer any claim processing questions, please call 1-877-264-2440.

  • Dose Tracking/Reminders
  • Supportive messages each day of treatment
  • Symptom Library (including advice and tips for relief)
  • Meditation Timer

Patients do not need to sign up—they simply download the app to start immediately!

LUminate Support Mobile App
Download at the App Store
Get it on Google Play

US WorldMeds® Patient Assistance Program

US WorldMeds recognizes that some of your patients may have no health insurance of any kind and won’t be able to pay cash for LUCEMYRA treatment. As we want every patient who needs LUCEMYRA to receive it, we have developed the US WorldMeds Patient Assistance Program, which will provide LUCEMYRA treatment free to those patients who meet certain income and other eligibility requirements.

Download the US WorldMeds Patient Assistance Program Application and provide it to your patients without health insurance whom you think may be eligible for the program.

For more information about the US WorldMeds Patient Assistance Program, contact us at 877-438-9759 or 218-444-8217.

Patients whose prescriptions are paid in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program, are not eligible for this program.

Patient Education Brochure

Give your patients this practical and informative resource to help get them through opioid withdrawal. This brochure covers how and why opioid withdrawal occurs and provides your patients with a comprehensive overview of LUCEMYRA.

Caregiver Discussion Guide

Bring caregivers into the treatment conversation with the Caregiver Discussion Guide. Designed specifically with caregivers in mind, this guide can help provide background on why withdrawal occurs, how it can be managed, as well as helpful advice when discussing withdrawal with their loved one.

“What to Expect” Patient Leaflet

Establish treatment expectations for your patients by offering this 2-page leaflet along with prescriptions for LUCEMYRA. The leaflet will outline a treatment plan and what patients can expect during their 7 to 14 days of treatment.